THD Breast Cancer Grand Rounds - Somatic and Germline Genetic Testing in Patient Care
Target Audience
This online interprofessional educational enduring material is designed for physicians and clinical staff involved in the screening, evaluation, diagnosis and treatment of breast cancer. Its purpose is to develop the skills and resources needed to stage the cancer, indicate prognosis, make appropriate genetics recommendations, meet national treatment guidelines and address the appropriateness of clinical trials for patients. Needs exist to provide strategies on approaching diagnosis and treatment of breast cancer with the newest standards and technologies.
Learning Objectives
At the end of this online enduring material, participants should be able to:
- Describe the clinical distinctions between somatic and germline genetic testing and how to discuss this testing with your patients
- Review common clinical indications for somatic and germline genetic testing
- Discuss the benefits and limitations of somatic only, germline only and paired somatic/germline testing strategies
Available Credit
- 0.75 AMA PRA Category 1 Credit™
In support of improving patient care, Texas Health Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The Texas Health Resources designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 0.75 Attendance
- 0.75 Nursing Contact Hour(s)In support of improving patient care, Texas Health Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.